Medicine-food homologous products are barred from making efficacy claims, and market education poses great challenges: Qingfan has transformed 100,000 TCM clinics into sales and trust access points, unlocking the trillion-scale market for TCM integrated into everyday life.
Traditional Chinese medicine (TCM) is a way of life for the Chinese people. It has never been confined to hospital clinics, but has long been integrated into the daily clothing, food, housing and transportation of the Chinese public. As the first platform in China to launch three core functions including a TCM lifestyle mall, high-quality TCM clinic project recommendation, and a community for TCM enthusiasts, the "Qingfan" TCM lifestyle co-construction and sharing platform built by Nanjing Zhiyue Cloud Link Data Technology Co., Ltd. is unlocking the trillion-yuan TCM big health market with a brand-new operation model.
TCM lifestyle products cover medicinal and edible homologous foods, external health care products, TCM cultural and creative derivatives and more. As the efficacy of such products cannot be publicized per relevant regulations, the sector has long faced the problem of insufficient market education. "Qingfan" has established close cooperation with a portion of the 100,000 TCM clinics nationwide, allowing TCM practitioners to convey accurate product information to consumers, and taking TCM hospitals as a key sales link, to solve the two major pain points restricting the development of TCM lifestyle at the same time.
The core target customers of Qingfan are the long-term established clients of TCM clinics. A typical TCM clinic usually has 1,000 to 30,000 established clients, most of whom are middle-aged and elderly people, and around 70% of TCM clinics have WeChat groups for their clients. This group of users has high compliance with their corresponding TCM clinics, the vast majority of them are TCM enthusiasts, and each of them can influence their whole family to trust and use TCM services and products. By encouraging cooperative TCM clinics to convert their established clients into Qingfan members, Qingfan can quickly achieve its customer acquisition targets.
The TCM lifestyle market has huge growth potential. According to data from iiMedia Research, the scale of China's big health industry has exceeded 10 trillion yuan in 2025, among which non-medical consumption tracks such as TCM health preservation and medicinal-edible homology have exceeded one trillion yuan, with a growth rate far higher than the industry average. The Qingfan platform plans to develop 10,000 cooperative TCM clinics and accumulate 10 million members within 1 to 3 years. Through integrated member marketing operation, Qingfan will eventually reach a sales scale of tens of billions of yuan, while promoting the transformation of TCM research achievements in public hospitals, supporting the productization of proven folk TCM remedies, and opening up new growth space for the whole industry.
The Qingfan model builds a four-network integrated operation system: taking the internet platform as the sky network, the sales teams of TCM clinics and Qingfan as the ground network, the process of TCM clinics converting their established clients into Qingfan members as the human network, and the cooperation with provincial TCM hospitals across the country to provide professional training and empowerment for TCM clinics as the learning network.
The Chief Scientist of Qingfan is Zheng Wensheng, a pharmacologist and doctoral supervisor at the Chinese Academy of Medical Sciences and Peking Union Medical College, who completed his bachelor's degree in TCM and postdoctoral research in pharmaceutics. Founding partner Chu Licheng has 28 years of experience in the TCM industry, holds a bachelor's degree in mathematics and a master's degree in management from Guanghua School of Management. He is good at strategic thinking, excels in market layout and sales practice, and once served as the core sales leader to lead a TCM enterprise through 11 years of development from scratch to an annual sales volume of 3.5 billion yuan, with deep insight into the core pain points of the industry. Founding partner Yang Zhengyong has 22 years of experience in TCM production, supply and marketing, and is a former senior TCM engineer at Kangmei Pharmaceutical. Chu Licheng and Yang Zhengyong have abundant TCM practitioner resources, and are among the very few professionals in the country who have deep, long-term connections with TCM hospitals and grassroots TCM clinics. Another founding partner, Yang Lisha, is a licensed lawyer with more than 20 years of experience in the pharmaceutical industry, and is the former Marketing Director of Bayer Pharmaceuticals China Region.
At present, the mini-program and standalone APP of the Qingfan platform have been officially launched and put into operation. In the trial operation stage, it has connected more than 200 cooperative TCM clinics and accumulated over 2,000 registered members, and all work is being steadily advanced in accordance with the established plan.
Qingfan has also integrated multiple production enterprises including Guizhou Xumingkang, and owns production lines for medicinal-edible homologous products, external health care products, TCM decoction pieces and other categories, which can support flexible small-batch customized production. Among these advantages, Guizhou Province's exclusive policy for external health product approval numbers is a particularly prominent competitive edge.
Qingfan currently owns a number of exclusive products: its fried coix seed product holds 1 invention patent and 5 utility model patents, with an estimated market potential of 500 billion yuan; its uric acid-lowering compound product fills the long-standing gap in the industry, with a market potential exceeding one trillion yuan. Its product portfolio also includes the TCM sleep-aiding pillow transformed from the research achievement of Air Force General Hospital, hemorrhoid-relief wet toilet paper, compound TCM eye mask, and herbal paste formulas for nine different human constitutions.
The core profit model of the project at the current stage is the sales of TCM lifestyle products. The start-up operation is mainly funded by the founding team's self-raised capital. The project is now open for seed round financing, planning to raise 2 to 4 million yuan with a post-investment valuation of 20 million yuan. The raised funds will be mainly used for platform promotion and team expansion, and the project plans to launch the second round of financing of about 20 million yuan later to meet the cash flow demand during the rapid development stage.
In the future, the Qingfan platform will continue to enrich its product matrix, fully implement the four-network integrated operation model, and realize its vision of "making big health business accessible and easy for all practitioners".